Product Code: ETC417502 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The corticosteroids market in Malaysia is poised for growth due to the rising prevalence of inflammatory and autoimmune diseases. Corticosteroids, known for their anti-inflammatory properties, are commonly prescribed by healthcare professionals. As the healthcare infrastructure in Malaysia continues to develop, the demand for corticosteroids is expected to rise. However, there is a need for stringent regulation and monitoring of corticosteroid usage to mitigate potential side effects and overuse.
The corticosteroids market in Malaysia is poised for substantial growth in the coming years. Several factors contribute to this positive outlook. Firstly, the increasing incidence of inflammatory and autoimmune diseases is driving the demand for corticosteroids. Additionally, the expanding geriatric population, which is more prone to such conditions, is a significant driver. Furthermore, advancements in drug delivery technologies and formulations are enhancing the efficacy and safety profile of corticosteroids, further boosting their market growth.
Corticosteroids are a class of drugs with anti-inflammatory properties. The market in Malaysia is influenced by factors such as the prevalence of inflammatory conditions, healthcare policies, and advancements in pharmaceutical formulations.
The corticosteroids market in Malaysia saw increased demand during the COVID-19 pandemic, as these drugs were used to manage severe cases of the virus. This surge in demand led to supply shortages and price fluctuations. While the market experienced challenges related to availability, efforts were made to prioritize healthcare needs. As the pandemic subsides, the market for corticosteroids is expected to return to a more stable state.
Corticosteroids have applications in various medical treatments, including anti-inflammatory and immunosuppressive therapies. Leading pharmaceutical companies like GlaxoSmithKline, AstraZeneca, and Sanofi are active in the Malaysia market. Market growth is influenced by factors such as healthcare expenditure, disease prevalence, and research advancements. Companies should focus on product innovation and regulatory compliance to succeed in this market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Corticosteroids Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Corticosteroids Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Corticosteroids Market - Industry Life Cycle |
3.4 Malaysia Corticosteroids Market - Porter's Five Forces |
3.5 Malaysia Corticosteroids Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Malaysia Corticosteroids Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Malaysia Corticosteroids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin disorders and autoimmune diseases in Malaysia |
4.2.2 Growing awareness about corticosteroids and their effectiveness in treating various medical conditions |
4.2.3 Rise in healthcare expenditure and investments in healthcare infrastructure in Malaysia |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the use of corticosteroids in certain medical applications |
4.3.2 Concerns regarding the side effects and long-term use of corticosteroids |
4.3.3 Competition from alternative treatment options such as herbal remedies and non-steroidal medications |
5 Malaysia Corticosteroids Market Trends |
6 Malaysia Corticosteroids Market, By Types |
6.1 Malaysia Corticosteroids Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Corticosteroids Market Revenues & Volume, By Application, 2021-2031F |
6.1.3 Malaysia Corticosteroids Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.1.4 Malaysia Corticosteroids Market Revenues & Volume, By Rhuematology Indications, 2021-2031F |
6.1.5 Malaysia Corticosteroids Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.1.6 Malaysia Corticosteroids Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.1.7 Malaysia Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
6.2 Malaysia Corticosteroids Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Corticosteroids Market Revenues & Volume, By Hospitals, 2021-2031F |
6.2.3 Malaysia Corticosteroids Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.4 Malaysia Corticosteroids Market Revenues & Volume, By Research Institutes, 2021-2031F |
6.2.5 Malaysia Corticosteroids Market Revenues & Volume, By Others, 2021-2031F |
7 Malaysia Corticosteroids Market Import-Export Trade Statistics |
7.1 Malaysia Corticosteroids Market Export to Major Countries |
7.2 Malaysia Corticosteroids Market Imports from Major Countries |
8 Malaysia Corticosteroids Market Key Performance Indicators |
8.1 Patient adherence rate to corticosteroid treatment plans |
8.2 Number of healthcare providers prescribing corticosteroids |
8.3 Rate of new product developments and innovations in the corticosteroids market |
9 Malaysia Corticosteroids Market - Opportunity Assessment |
9.1 Malaysia Corticosteroids Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Malaysia Corticosteroids Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Malaysia Corticosteroids Market - Competitive Landscape |
10.1 Malaysia Corticosteroids Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Corticosteroids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |